The efficacy of serum cell death biomarkers for diagnosing biliary tract cancer

The efficacy of serum cell death biomarkers for diagnosing biliary tract cancer

Abstract In this study, we determined the efficacy of the cell death biomarker cytokeratin 18 for diagnosing biliary tract cancer (BTC). We recruited 36 patients with BTC (Malignant group) and 45 patients with benign biliary tract disease (Benign group) for this study. We used M30 and M65 as cell de...

Full description

Saved in:
Bibliographic Details
Main Authors: Mitsuru Sugimoto, Kazumichi Abe, Manabu Hayashi, Tadayuki Takagi, Rei Suzuki, Naoki Konno, Hiroyuki Asama, Yuki Sato, Hiroki Irie, Ko Watanabe, Jun Nakamura, Hitomi Kikuchi, Yuichi Waragai, Mika Takasumi, Minami Hashimoto, Takuto Hikichi, Yoshihiro Nozawa, Hiromasa Ohira
Format: article
Language:EN
Published: Nature Portfolio 2018
Subjects:
Cell Death Biomarkers
Biliary Tract Cancer (BTC)
Biliary Cytology
Malignant Group
Benign Biliary Tract Disease
Medicine
R
Science
Q
Online Access:https://doaj.org/article/3a2bfe63fe304f33a6de52b0dae27cfd
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items